These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 32489022

  • 1. [Application of Reyanning Mixture in evaluating combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome].
    Bao L, Shi YJ, Geng ZH, Sun J, Zhao RH, DU CQ, Chu YJ, Cui XL.
    Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(7):1465-1472. PubMed ID: 32489022
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic effect of Compound Qinlan Oral Liquid on treating combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome].
    Bao YY, Shi YJ, Guo SS, Geng ZH, Bao L, Sun J, Zhao RH, Gao YJ, Fang TH, Meng J, Cui XL.
    Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(7):1473-1480. PubMed ID: 32489023
    [Abstract] [Full Text] [Related]

  • 3. [Study on therapeutic effect of Chaiyin Particles on combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome based on regulation of immune function].
    Bao YY, Shi YJ, Guo SS, Geng ZH, Gao YJ, Bao L, Zhao RH, Sun J, Zhang GM, Guan YX, Cui XL.
    Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(13):3020-3027. PubMed ID: 32726007
    [Abstract] [Full Text] [Related]

  • 4. [Meta-analysis of single-group rate of the distribution of traditional Chinese medicine syndromes in 2 139 patients with coronavirus disease 2019].
    Li X, Liu W, He W, Xie Y, Li J.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):664-670. PubMed ID: 32684209
    [Abstract] [Full Text] [Related]

  • 5. [Clinical comprehensive evaluation of Reyanning Mixture in treatment of acute upper respiratory tract infection (heat-toxin attacking lung syndrome)].
    Lyu J, Wang ZF, Xie YM, Cheng FJ, Zhang Q, Cui X.
    Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(6):1476-1483. PubMed ID: 35347946
    [Abstract] [Full Text] [Related]

  • 6. [Study on traditional Chinese medicine common syndrome characteristic of coronavirus disease 2019 based on latent structure combined with system clustering analysis].
    Feng Z, Xie Y, Chun L, Li J.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):537-543. PubMed ID: 32576343
    [Abstract] [Full Text] [Related]

  • 7. Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a.
    Zhao J, Yang X, Wang C, Song S, Cao K, Wei T, Ji Q, Zheng W, Li J, Zhou X, Liu J.
    Biomed Pharmacother; 2020 Sep; 129():110436. PubMed ID: 32768938
    [Abstract] [Full Text] [Related]

  • 8. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J, Zhao J, Han M, Meng F, Zhou J.
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [Abstract] [Full Text] [Related]

  • 9. [Moxibustion therapy in prevention and treatment of coronavirus disease 2019 (COVID-19): construction and application of non-contact diagnosis and treatment mode].
    Chen X, Huang W, Liu BY, Wang H, He LY, Zhao H, Gang WJ, Wei D, Ding DG, Pan HL, Wang JY, Teng JY, Mao HF, Tan SC, Xu XY, Yao M, Liu SM, Li Y, Wang Q, Liu YR, Yu L, Shen C, Wang JJ, Cheng Y, Zhan MM, Zheng YW, Song AQ, Zhou ZY, Jing XH.
    Zhongguo Zhen Jiu; 2020 Oct 12; 40(10):1027-33. PubMed ID: 33068341
    [Abstract] [Full Text] [Related]

  • 10. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.
    Conti P, Gallenga CE, Tetè G, Caraffa A, Ronconi G, Younes A, Toniato E, Ross R, Kritas SK.
    J Biol Regul Homeost Agents; 2020 Oct 12; 34(2):333-338. PubMed ID: 32228825
    [Abstract] [Full Text] [Related]

  • 11. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
    Wang F, Hou H, Luo Y, Tang G, Wu S, Huang M, Liu W, Zhu Y, Lin Q, Mao L, Fang M, Zhang H, Sun Z.
    JCI Insight; 2020 May 21; 5(10):. PubMed ID: 32324595
    [Abstract] [Full Text] [Related]

  • 12. A retrospective study of Reyanning mixture in elderly patients infected with SARS-CoV-2 Omicron variant.
    Liu C, Wu X, Yang H, Xu X, Chen C, Wu L, Zhang W, Shi H, Fei Y, Sun Y, Wu H, Zhou S, Fang B.
    Front Pharmacol; 2023 May 21; 14():1185122. PubMed ID: 37547325
    [Abstract] [Full Text] [Related]

  • 13. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients.
    Wan S, Yi Q, Fan S, Lv J, Zhang X, Guo L, Lang C, Xiao Q, Xiao K, Yi Z, Qiang M, Xiang J, Zhang B, Chen Y, Gao C.
    Br J Haematol; 2020 May 21; 189(3):428-437. PubMed ID: 32297671
    [Abstract] [Full Text] [Related]

  • 14. Clinical characteristics of 71 patients with coronavirus disease 2019.
    Xiao M, Hou M, Liu X, Li Z, Zhao Q.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jul 28; 45(7):790-796. PubMed ID: 32879082
    [Abstract] [Full Text] [Related]

  • 15. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
    Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, Men D, Huang Q, Liu Y, Yang B, Ding J, Li F.
    Clin Infect Dis; 2020 Nov 05; 71(8):1937-1942. PubMed ID: 32301997
    [Abstract] [Full Text] [Related]

  • 16. SARS-CoV-2, the Virus that Causes COVID-19: Cytometry and the New Challenge for Global Health.
    Cossarizza A, De Biasi S, Guaraldi G, Girardis M, Mussini C, Modena Covid-19 Working Group (MoCo19)#.
    Cytometry A; 2020 Apr 05; 97(4):340-343. PubMed ID: 32187834
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of Traditional Chinese Medicine Diagnosis and Treatment Strategies for COVID-19 Based on "The Diagnosis and Treatment Program for Coronavirus Disease-2019" from Chinese Authority.
    Zhao ZH, Zhou Y, Li WH, Huang QS, Tang ZH, Li H.
    Am J Chin Med; 2020 Apr 05; 48(5):1035-1049. PubMed ID: 32668970
    [Abstract] [Full Text] [Related]

  • 18. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an in vivo hACE2 transfection mouse model.
    Liang Y, Li H, Li J, Yang ZN, Li JL, Zheng HW, Chen YL, Shi HJ, Guo L, Liu LD.
    Zool Res; 2020 Nov 18; 41(6):621-631. PubMed ID: 33045777
    [Abstract] [Full Text] [Related]

  • 19. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
    Zhao X, Zheng S, Chen D, Zheng M, Li X, Li G, Lin H, Chang J, Zeng H, Guo JT.
    J Virol; 2020 Aug 31; 94(18):. PubMed ID: 32641482
    [Abstract] [Full Text] [Related]

  • 20. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P, Caraffa A, Tetè G, Gallenga CE, Ross R, Kritas SK, Frydas I, Younes A, Di Emidio P, Ronconi G.
    J Biol Regul Homeost Agents; 2020 Aug 31; 34(5):1629-1632. PubMed ID: 32945158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.